Lipocine Inc. (LPCN:NASDAQ) soared at $0.77, representing a gain of 67.4%. The stock got featured on our News Catalysts scanner on Tue 11 Feb 20 at 07:38 PM in the 'RECOMMENDATION' category. From Fri 31 Jan 20, the stock recorded 35.71% Up Days and 33.33% Green Days
The share price of the company has been moving sideways in recent weeks.
About Lipocine Inc. (LPCN:NASDAQ)
Lipocine Inc is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men's and women's health.
Top 10 Gainers:
- Lipocine Inc. (LPCN:NASDAQ), 67.39%
- Correvio Pharma Corp. (CORV:NASDAQ), 61.12%
- NanoViricides, Inc. (NNVC:NYSEMKT), 38.37%
- VelocityShares Daily 2x VIX Short-Term ETN (TVIX:NASDAQ), 37.05%
- Ambow Education Holding Ltd. (AMBO:NYSEMKT), 34.91%
- Endologix, Inc. (ELGX:NASDAQ), 34.35%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 28.85%
- NYSE Tick Pilot Test Sym-Contro (NTEST:NYSE), 27.92%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 27.24%
- Document Security Systems, Inc. (DSS:NYSEMKT), 26.33%